Metabolic biomarkers in patients with mild cognitive impairment and Parkinson's disease
Metabolic biomarkers in patients with mild cognitive impairment and Parkinson's disease
Sep 7, 2015 1518 views 
0.25
0.5
0.75
1.25
1.5
1.75
2
Voxel-by-voxel comparison of FDG/PET brain images of patient groups with MCI, PD and PD-MCI and normal controls will be presented which reveal hyper- and hypometabolic regional differences between groups. Expression of specific AD-related metabolic pattern (ADRP) and Parkinson disease cognitive pattern (PDCP) recently identified using spatial covariance analysis with FDG/PET data, will be shown for individual subjects and its ability to differentiate between groups, and correlation with CSF biomarkers for AD will be discussed.